Photo by Simon Daoudi on Unsplash
Apple Resumes Smartwatch Sales After Patent Dispute
December 27, 2023
Apple has won an appeal to resume selling its smartwatches after the U.S. Court of Appeals for the Federal Circuit paused an import ban. The ban was issued by the U.S. International Trade Commission (ITC), which ruled that Apple violated patents of Masimo, a medical technology company.
The patent dispute centers on the blood oxygen monitoring technology, with Masimo accusing Apple of stealing its pulse oximetry tech. Apple countersued, suggesting Masimo’s lawsuit was a strategic move for its own smartwatch launch. While the case could cost either company millions, analysts suggest the bad publicity could be more damaging for Apple.
In a ruling on Wednesday, the appeals court stated it would pause the ban while it “considers Apple’s motion for a longer-term pause during the appeals process.” The court’s reprieve allows Apple to resume sales of its Apple Watch Series 9 and Ultra 2 models, which include the disputed technology.
“We are thrilled to return the full Apple Watch lineup to customers in time for the new year,” a representative from Apple said in a statement.
However, this pause is temporary, as the ITC has until Jan. 10 to respond to Apple’s request. The issue has raised questions about corporate ethics and technological innovation. Despite the potential financial implications of developing its own blood monitoring software, experts argue that the larger concern for Apple is the accusation of technology theft from competitors, which could impact its public image and future health wearable products.
The U.S. Customs and Border Protection is deliberating on whether the redesigned versions of Apple’s watches infringe upon Masimo’s patents and if they can be imported. The decision is due on Jan 12. In the meantime, Apple’s less expensive model, the Apple Watch SE, which lacks a pulse oximeter, is not affected by the ban, and sales continue.
Recent News
Tesla Axes All but 3 Jobs Out of 3,400 Listed Roles in North America
Tesla has axed more than 3,400 job postings, leaving only three in North America.
AstraZeneca Pulls COVID-19 Vaccine Amid Disappearing Demand
AstraZeneca is the latest company to feel the COVID-19 vaccine demand slump.
New Starbucks Artist Collaboration Merch Announced
Inspired by personal experiences and cultural heritage, artist Monyee Chau brings forth a collection under the Starbucks Artist Collaboration Series set to debut this summer.
FDA Says Eating Yogurt May Help With One Common Disease
The Food and Drug Administration claims that yogurt could help with one common disease, but there’s a catch as to not mislead consumers.